Nemocnica Poprad, as

Poprad 05801

1 studies enrolling now · 5 studies all time

What they study most

Bile Duct Cancer, Diabetic Retinopathy, Endometrial Cancer, Esophageal Cancer, Gastric Cancer, Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Hepatocellular Carcinoma, Lung Squamous Cell Carcinoma, Melanoma Cancer, Neovascular Age-related Macular Degeneration, Obesity

Studies at this site

• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity — Recruiting now
• Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD — Completed
• Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. — Stopped early
• Non-proliferative Diabetic Retinopathy Treated With Runcaciguat — Completed
• Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma — Completed